Oorsprong van het eerstegraads netwerk van Nicholas Conrad Burgin
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Eisai Manufacturing Ltd.
 Eisai Manufacturing Ltd. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., Eisai Manufacturing Ltd. is a pharmaceutical company based in Hatfield, UK. The British company's focus is on developing new medicines for neglected tropical diseases and malaria, improving access to medicines for non-communicable diseases, and promoting sustainability. Eisai Manufacturing is committed to funding the 3rd phase of health innovative technology fund activities. The company's official corporate website provides information on their initiatives and HHC concept.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Eisai Ltd. (United Kingdom)
 Eisai Ltd. (United Kingdom) Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., Eisai Ltd. is a British company that develops pharmaceutical products. The company is based in Hatfield, UK. The company was founded in 1988. Gary Bryan Hendler has been the CEO of the company since 2008.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Eisai Europe Ltd.
 Eisai Europe Ltd. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., Eisai Europe Ltd. is a British pharmaceutical company that manufactures and distributes pharmaceutical products. The company is based in Hatfield, UK and was founded in 2004.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Eisai Farmacéutica SA
 Eisai Farmacéutica SA Pharmaceuticals: MajorHealth Technology Eisai Farmacéutica SA is a pharmaceutical company based in Madrid, Spain. Eisai Farmacéutica SA operates as a Spanish pharmaceutical company. Part of Eisai Co., Ltd., the company was founded in 2001. The CEO is Gary Bryan Hendler.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Eisai GmbH
 Eisai GmbH Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., Eisai GmbH is a German pharmaceutical company that specializes in research and development of innovative treatments for neurological and oncological diseases. The company is based in Frankfurt, Germany. The CEOs of the company are Gary Bryan Hendler, Nicholas Conrad Burgin.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Nicholas Conrad Burgin via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| EISAI CO., LTD. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Eisai SAS
 Eisai SAS Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., Eisai SAS is a French pharmaceutical company founded in 1996. The company is based in Courbevoie, France and strives to improve the lives of those who could benefit from their medicines. Eisai focuses its research on oncology and neurology, two areas presenting challenges in terms of public health. The company is committed to the fight against serious diseases, alongside patients, healthcare professionals, and public authorities. | Pharmaceuticals: Major | Chairman | |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Pharmaceuticals: Major | Chief Executive Officer |
Statistieken
Internationaal
| Japan | 2 |
| Frankrijk | 2 |
| Verenigde Staten | 2 |
Sectoraal
| Health Technology | 4 |
Operationeel
| Director/Board Member | 11 |
| Chief Executive Officer | 6 |
| Corporate Officer/Principal | 5 |
| Chairman | 5 |
| Director of Finance/CFO | 1 |
Sterkste connecties
- Beurs
- Insiders
- Nicholas Conrad Burgin
- Bedrijfsconnecties
